Coronary Artery Bypass Graft Surgery Clinical Trial Analysis

Summary

Global Markets Direct's "Coronary Artery Bypass Graft Surgery Clinical Trials Analysis" is an essential source of data and information pertaining to product clinical trials being carried out by Coronary Artery Bypass Graft Surgery device manufacturers, globally. The report provides exhaustive information on each clinical investigation study with coverage detailed coverage on the pipeline products these trials are being carried out for.

Scope

• The report provides analysis and review of the key clinical trials being carried out globally and across key Coronary Artery Bypass Graft Surgery market categories - Endoscopic Vein Harvesting Device,Anastomosis Device,Minimally Invasive OPCAB Device
• The report covers information on each product being clinically tested with detailed coverage on the pipeline product profile, the indication it's being investigated for etc.
• The report provides an in-depth analysis of the clinical trials with information on trial phase, trial 0status, trial acronym, purpose, inclusion and exclusion criteria, description, design, intervention, investigator information, primary and secondary end-points and trial results
• The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by Global Markets Direct's team of industry experts.

Reasons to Buy

• Effectively plan your Mergers and Acquisitions and partnership strategies by identifying companies with the most promising pipeline.
• Stay ahead of the information curve in the fast changing Coronary Artery Bypass Graft Surgery market.
• Plan in-licensing and out-licensing opportunities through review of pipeline products and technologies.
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
• Proactively plan and execute your competitive strategies by identifying clinical trials status of the leading competitive products in pipeline.
• Stay ahead of competition by understanding the changing competitive landscape in specific geographies.

Contents

• 1 List of Tables
• 1.2 List of Figures
• 2 Coronary Artery Bypass Graft Surgery Clinical Trials
  • 2.1 Coronary Artery Bypass Graft Surgery Clinical Trial By Equipment Type
  • 2.2 Coronary Artery Bypass Graft Surgery Clinical Trials By Trial Phase and Trial Status
  • 2.3 Coronary Artery Bypass Graft Surgery Pipeline Products By Development Stage
  • 2.4 Coronary Artery Bypass Graft Surgery Pipeline Products By Therapy Area
  • 2.5 Coronary Artery Bypass Graft Surgery Pipeline Products By News Summary
  • 2.6 Coronary Artery Bypass Graft Surgery CardioPass
    • 2.6.1 CardioPass - European Clinical Trial
    • 2.6.2 CardioPass Phase II Brazilian Clinical Trials
  • 2.7 Coronary Artery Bypass Graft Surgery Artificial Coronary Graft
    • 2.7.1 Evaluating the clinical benefits of Artificial Coronary Graft
  • 2.8 Coronary Artery Bypass Graft Surgery Endo MVP Distal Anastomotic Device
    • 2.8.1 Clampless Arterial Coronary Artery Bypass Grafting with the Use of Magnetic Coupling Devices
    • 2.8.2 Magnetic Vascular Port in Minimally Invasive Direct Coronary Artery Bypass Grafting
  • 2.9 Coronary Artery Bypass Graft Surgery Cardiogold
    • 2.9.1 Pilot Study On The Safety Of Myocardial Regeneration By Direct Epicardial Shock Wave Therapy In Combination With Coronary Artery Bypass Grafting
• 3 Recent Developments
  • 3.1 Product News
    • 3.1.1 Nov 10, 2008: Cardica Announces Case Report Of C-Port System In Brain Arterial Bypass
    • 3.1.2 Sep 29, 2008: Internationally Renowned Cardiothoracic Surgeon Performs Robotic Cardiac Bypass Surgery Using Revolutionary Anastomosis Device
    • 3.1.3 Jul 11, 2008: CardioTech International Receives FDA Approval For Export Of Second Graft Size For CardioPass Clinical Trial
    • 3.1.4 May 10, 2007: Synovis Life Technologies Receives US Patent For Flow Coupler
  • 3.2 Product Approvals
    • 3.2.1 Jul 11, 2008: CardioTech International Receives FDA Approval For Export Of Second Graft Size For CardioPass Clinical Trial
  • 3.3 Clinical Trials
    • 3.3.1 Nov 10, 2008: Cardica Announces Case Report Of C-Port System In Brain Arterial Bypass
• 4 Appendix
  • 4.1 Methodology
    • 4.1.1 Coverage
    • 4.1.2 Secondary Research
    • 4.1.3 Primary Research
    • 4.1.4 Expert Panel Validation
  • 4.2 Contact Us
  • 4.3 About Global Markets Direct
  • 4.4 Disclaimer
• 1 List of Tables
  • Table 1: Coronary Artery Bypass Graft Surgery Clinical Trial By Equipment Type
  • Table 2: Coronary Artery Bypass Graft Surgery Clinical Trials By Trial Phase and Trial Status
  • Table 3: Coronary Artery Bypass Graft Surgery Pipeline Products By Development Stage
  • Table 4: Coronary Artery Bypass Graft Surgery Pipeline Products By Therapy Area
  • Table 5: Coronary Artery Bypass Graft Surgery Pipeline Products By News Summary
  • Table 6: CardioPass - CardioPass - European Clinical Trial
  • Table 7: CardioPass - CardioPass Phase II Brazilian Clinical Trials
  • Table 8: Artificial Coronary Graft - Evaluating the clinical benefits of Artificial Coronary Graft
  • Table 9: Endo MVP Distal Anastomotic Device - Clampless Arterial Coronary Artery Bypass Grafting with the Use of Magnetic Coupling Devices
  • Table 10: Endo MVP Distal Anastomotic Device - Magnetic Vascular Port in Minimally Invasive Direct Coronary Artery Bypass Grafting
  • Table 11: Cardiogold - Pilot Study On The Safety Of Myocardial Regeneration By Direct Epicardial Shock Wave Therapy In Combination With Coronary Artery Bypass Grafting
• 1.2 List of Figures
  • Figure 1: Global Markets Direct Methodology